Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yannick Allanore

Showing results (221-230 of 493) with videos related to

Pageof 50
Sort By:
Arthritis Research & Therapy|August 31, 2018
T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosisGonçalo Boleto, Christophe Guignabert, Sonia Pezet, et al.
Seminars in Arthritis and Rheumatism|November 7, 2024
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritisOmar Al Tabaa, Sophie Hecquet, Marion Thomas, et al.
ACR Open Rheumatology|July 19, 2022
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled TrialShervin Assassi, Oliver Distler, Yannick Allanore, et al.
Rheumatology (Oxford, England)|January 19, 2010
Dermal tissue and cellular expression of fibrillin-1 in diffuse cutaneous systemic sclerosisJulien Wipff, Jérôme Avouac, Monique Le Charpentier, et al.
Arthritis Research & Therapy|December 23, 2025
Soquelitinib inhibition of IL-2-inducible T cell kinase ameliorates lung damage in murine models of systemic sclerosisGonçalo Boleto, Anne Cauvet, Christophe Guignabert, et al.
RMD Open|February 23, 2025
Continued nintedanib in patients with systemic sclerosis-associated interstitial lung disease: 3-year data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Arthritis Research & Therapy|January 11, 2022
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysisMichael Kreuter, Francesco Del Galdo, Corinna Miede, et al.
The Journal of Rheumatology|August 17, 2013
Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohortsHeather Gladue, Virginia Steen, Yannick Allanore, et al.
Rheumatology (Oxford, England)|November 2, 2021
Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patientsJérôme Avouac, Corinne Miceli-Richard, Alice Combier, et al.
Rheumatology (Oxford, England)|October 5, 2017
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre studyGregor John, Yannick Allanore, Pamela Polito, et al.
Pageof 50

Showing results (221-230 of 493) with videos related to

Sort By:
Pageof 50
Arthritis Research & Therapy|August 31, 2018
T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosisGonçalo Boleto, Christophe Guignabert, Sonia Pezet, et al.
Seminars in Arthritis and Rheumatism|November 7, 2024
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritisOmar Al Tabaa, Sophie Hecquet, Marion Thomas, et al.
ACR Open Rheumatology|July 19, 2022
Effect of Nintedanib on Progression of Systemic Sclerosis-Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled TrialShervin Assassi, Oliver Distler, Yannick Allanore, et al.
Rheumatology (Oxford, England)|January 19, 2010
Dermal tissue and cellular expression of fibrillin-1 in diffuse cutaneous systemic sclerosisJulien Wipff, Jérôme Avouac, Monique Le Charpentier, et al.
Arthritis Research & Therapy|December 23, 2025
Soquelitinib inhibition of IL-2-inducible T cell kinase ameliorates lung damage in murine models of systemic sclerosisGonçalo Boleto, Anne Cauvet, Christophe Guignabert, et al.
RMD Open|February 23, 2025
Continued nintedanib in patients with systemic sclerosis-associated interstitial lung disease: 3-year data from SENSCIS-ONYannick Allanore, Madelon C Vonk, Oliver Distler, et al.
Arthritis Research & Therapy|January 11, 2022
Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysisMichael Kreuter, Francesco Del Galdo, Corinna Miede, et al.
The Journal of Rheumatology|August 17, 2013
Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohortsHeather Gladue, Virginia Steen, Yannick Allanore, et al.
Rheumatology (Oxford, England)|November 2, 2021
Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patientsJérôme Avouac, Corinne Miceli-Richard, Alice Combier, et al.
Rheumatology (Oxford, England)|October 5, 2017
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre studyGregor John, Yannick Allanore, Pamela Polito, et al.
Pageof 50